TP53 and hematologic disorder: Since a recent work by Bernard et al.8 demonstrated that TP53 impairment determines CNVs which correlate with poor prognosis in hematological malignancies, we deeply analyzed TP53 mutational state and identified a novel deletion at the single-cell level.